2nd Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Medical Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania. .
2nd Medical Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania.
J Gastrointestin Liver Dis. 2024 Mar 29;33(1):102-106. doi: 10.15403/jgld-5024.
Functional dyspepsia (FD), a widespread and debilitating digestive disease, is thought to originate from disrupted gut-brain communication. The cause of FD is not completely understood, but recent evidence suggests it could be due to multiple factors and can vary among different patient groups. Factors like gut motility changes, increased sensitivity to pain in the gut, ongoing low-level inflammation, and increased gut permeability have all been linked to the development of FD. Additionally, changes in the gut microbiome have been suggested to play a significant role in the disease. The gut microbiota in the duodenum could either be a cause or a result of the immune and nervous system issues seen in FD, but the ways in which the gut flora in the small intestine affects gut function, digestive metabolites and symptoms are not yet clear, more studies being needed in order to completely assess the relationship between gastrointestinal microbiota and development and progression of FD. This review summarizes the available research on the relationship between FD and the microbiota and examines the various treatments, including probiotics, that have been shown to relieve symptoms. Finally, suggestions for improving diagnosis and treatment for those with FD are presented.
功能性消化不良(FD)是一种广泛存在且使人虚弱的消化系统疾病,其被认为源于肠道-大脑通讯的中断。FD 的病因尚未完全阐明,但最近的证据表明,其可能由多种因素引起,并且在不同患者群体中可能存在差异。诸如肠道蠕动变化、对肠道疼痛的敏感性增加、持续的低水平炎症和肠道通透性增加等因素都与 FD 的发展有关。此外,肠道微生物组的变化也被认为在该疾病中发挥了重要作用。十二指肠中的肠道微生物组可能是 FD 中免疫和神经系统问题的原因或结果,但小肠中的肠道菌群影响肠道功能、消化代谢物和症状的方式尚不清楚,需要更多的研究来全面评估胃肠道微生物组与 FD 的发展和进展之间的关系。本综述总结了 FD 与微生物组之间关系的现有研究,并探讨了各种已显示可缓解症状的治疗方法,包括益生菌。最后提出了改善 FD 患者诊断和治疗的建议。
J Gastrointestin Liver Dis. 2024-3-29
Neurogastroenterol Motil. 2022-11
Korean J Gastroenterol. 2025-4-25
J Ethnopharmacol. 2021-10-5
Metabolites. 2025-4-12